Ganesha (psychedelic)


Ganesha, also known as 3,4-dimethyl-2,5-dimethoxyamphetamine or as 3-methyl-DOM, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families. It is the 3-methyl derivative of DOM and the amphetamine derivative of 2C-G. The drug is taken orally.

Use and effects

In his book PiHKAL, Alexander Shulgin lists Ganesha's dose range as 24 to 32mg orally and its duration as 18 to 24hours. The drug's onset was variably described as slow over the course of 3hours or as rapid. The effects of Ganesha have been reported to include strong closed-eye visuals, an increased appreciation of music, and powerful relaxation and tranquility, among others. Shulgin named Ganesha after the Hindu deity, Ganesha. It is one of his "ten classic ladies", a series of methylated DOM derivatives.

Chemistry

Synthesis

The chemical synthesis of Ganesha has been described.

Homologues

Homologues of Ganesha include G-3, G-4, G-5, and G-N, among others.
CompoundDetailsStructure
G-3CAS #: 207740-36-1

Dose: 12–18mg

Duration: 8–12hours

Effects: Closed-eye imagery, no visuals, fantasy, no body load, neurological sensitivity, others

2C analogue: 2C-G-3
G-4CAS #: Unknown

Partially synthesized but not tested.

2C analogue: 2C-G-4
G-5CAS #: 133787-68-5

Dose: 14–20mg

Duration: 16–30hours

Effects: No visuals or other sensory effects, excellent mental activity, mental integration, lacking something important, little or no body load

2C analogue: 2C-G-5
G-NCAS #: 477904-62-4

Synthesized and tested at 2mg but not up to active levels

2C analogue: 2C-G-N
G-OCAS #: 774538-38-4

Described and/or synthesized but not tested

2C analogue: None

History

Ganesha was first described in the literature by Alexander Shulgin in his book PiHKAL in 1991.

Society and culture

Legal status

Canada

Ganesha is a controlled substance in Canada under phenethylamine blanket-ban language.

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

United States

Ganesha is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption. In addition, the drug may considered a controlled substance as a positional isomer of DOET.